Report on operations 2016: Strong growth and strengthened income
Fourth quarter: · Sales amounted to SEK 251 (199) million, corresponding to an increase of 26 percent in SEK. Net sales growth was 21 percent in local currency. · Operating income before depreciation and amortisation (EBITDA) amounted to SEK 96 (81) million, corresponding to a margin of 38 (41) percent. · Sales started of the newly launched EmbryoScope+ time-lapse incubator. · Net income amounted to SEK 60 (57) million, which gave earnings per share of SEK 2.74 (2.63). Whole year 2016: · Sales amounted to SEK 856 (722) million, corresponding to an increase of 19